Peter Fellner nominated to be elected to Biotie's Board of Directors
Dr. Fellner, 65, currently serves as Chairman of Consort Medical Plc, Chairman of Vernalis Plc and Chairman of Astex Therapeutics Ltd. Previously he served as CEO of Celltech Group plc from 1990 to 2003, and then as its Chairman until 2004. Prior to this he was CEO of Roche UK from 1986 to 1990. He has also served as a director of several other public companies.
Dr. Fellner has given his consent to Board service. He is independent of the company and independent of significant shareholders of the company.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.